Skip to main content
logo
Foghorn Therapeutics Inc. (FHTX)
NASDAQ: FHTX · Real-Time Price · USD
4.520
-0.150 (-3.21%)
Sep 10, 2026, 10:18 AM EDT - Market open

Foghorn Therapeutics Revenue

Foghorn Therapeutics had revenue of $16.07M in the quarter ending June 30, 2026, with 112.68% growth. This brings the company's revenue in the last twelve months to $36.74M, up 51.98% year-over-year. In the year 2025, Foghorn Therapeutics had annual revenue of $30.91M with 36.75% growth.

Revenue (ttm)
$36.74M
Revenue Growth
+51.98%
P/S Ratio
7.55
Revenue / Employee
$346,594
Employees
106
Market Cap
268.42M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202530.91M8.31M36.75%
Dec 31, 202422.60M-11.55M-33.83%
Dec 31, 202334.16M14.93M77.63%
Dec 31, 202219.23M17.91M1,357.77%
Dec 31, 20211.32M889.00K206.74%
Dec 31, 2020430.00K--
Dec 31, 2019---
Dec 31, 2018---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
MacroGenics175.14M
Fulcrum Therapeutics80.00M
Clinuvel Pharmaceuticals65.05M
Bicycle Therapeutics61.21M
Orchestra BioMed Holdings31.98M
AC Immune21.67M
ProQR Therapeutics21.05M
Fate Therapeutics6.49M
Revenue Rankings

FHTX News

More News